Reassessment of the role of methane production between irritable bowel syndrome and functional constipation

Journal of Gastrointestinal and Liver Diseases

Volumn 21, Issue 2, 2012, Pages 157-163

  Furnari, Manuele ^a   Savarino, Edoardo ^a   Bruzzone, Luca ^a   Moscatelli, Alessandro ^a   Gemignani, Lorenzo ^a   Gianini, Edoardo G ^a   Zentilin, Patrizia ^a   Dulbecco, Pietro ^a   Savarino, Vincenzo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Breath test; Constipation; Functional gastrointestinal disorders; Methane

Indexed keywords

HYDROGEN; METHANE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; BREATH ANALYSIS; CONSTIPATION; CONTROLLED STUDY; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; INTESTINE MOTILITY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIA; BREATH TESTS; CONSTIPATION; DEFECATION; DIARRHEA; FEMALE; GASTROINTESTINAL MOTILITY; GLUCOSE; HUMANS; HYDROGEN; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; MALE; METHANE; MIDDLE AGED; YOUNG ADULT;

EID: 84863425462     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008;20(suppl.1):121-129.
2. Kumar S, Misra A, Ghoshal UC. Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil 2010;16:299-305.
3. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-808.
4. Parodi A, Dulbecco P, Savarino E, et al. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol 2009;43:962-966.
5. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999;94:1327-1331.
6. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 2005;51 Suppl 1:1-22.
7. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563.
8. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2010;364:22-32.
9. Furnari M, Parodi A, Gemignani L, et al. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2010;32:1000-1006.
10. Scarpellini E, Gabrielli M, Lauritano CE, et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2007;25:781-786.
11. Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010;8:504-508.
12. Shaw AD, Davies GJ. Lactose intolerance: problems in diagnosis and treatment. J Clin Gastroenterol 1999;28:208-216.
13. Matthews SB, Waud JP, Roberts AG, Campbell AK. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005;81:167-173.
14. Sahakian AB, Jee SR, Pimentel M. Methane and the gastrointestinal tract. Dig Dis Sci 2010;55:2135-2143.
15. Pimentel M, Mayer AG, Park S, Chow EJ, Hasan A, Kong Y. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci 2003;48:86-92.
16. Hwang L, Low K, Khoshini R, et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS. Dig Dis Sci 2010;55:398-403.
17. Roccarina D, Lauritano EC, Gabrielli M, Franceschi F, Ojetti V, Gasbarrini A. The role of methane in intestinal diseases. Am J Gastroenterol 2010;105:1250-1256.
18. McKay LF, Eastwood MA, Brydon WG. Methane excretion in man - a study of breath, flatus, and faeces. Gut 1985;26:69-74.
19. Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008;6:759-764.
20. Parodi A, Sessarego M, Greco A, et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008;103:1257-1262.
21. Latella G, Pimpo MT, Sottili S, et al. Rifaximin improve symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003;18:55-62.
22. Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo controlled trial. Aliment Pharmacol Ther 1995;9:33-39.
23. Attaluri A, Jackson M, Valestin J, Rao SS. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 2010;105:1407-1411.
24. Cummings JH. Fermentation in the human large intestine: evidence and implications for health. Lancet 1983;1:1206-1209.
25. Levitt MD, Bond JH Jr. Volume, composition, and source of intestinal gas. Gastroenterology 1970;59:921-929.
26. Levitt MD. Production and excretion of hydrogen gas in man. N Eng J Med 1969;281:122-127.
27. Bond JH Jr, Engel RR, Levitt MD. Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria. J Exp Med 1971;133:572-588.
28. Melcher EA, Levitt MD, Slavin JL. Methane production and bowel function parameters in healthy subjects on low- and high-fiber diets. Nutr Cancer 1991;16:85-92.
29. Weaver GA, Krause JA, Miller TL, Wolin MJ. Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis. Gut 1986;27:698-704.
30. Wolin EA, Wolin MJ, Wolfe RS. Formation of methane by bacterial extracts. J Biol Chem 1963;238:2882-2886.
31. Christl SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992;102:1269-1277.
32. Macfarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992;72:57-64.
33. Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol 2006;290:G1089-1095.
34. Fiedorek SC, Pumphrey CL, Casteel HB. Breath methane production in children with constipation and encopresis. J Pediatr Gastroenterol Nutr 1990;10:473-477.
35. Peled Y, Weinberg D, Hallak A, Gilat T. Factors affecting methane production in humans. Gastrointestinal diseases and alterations of colonic flora. Dig Dis Sci 1987;32:267-271.
36. Pitcher MC, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 1996;39:1-4.
37. Gibson GR, Macfarlane GT, Cummings JH. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J Appl Bacteriol 1988; 65:103-111.
38. Gibson GR, Cummings JH, Macfarlane GT. Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol 1988;65: 241-247.
39. Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009;29 (Suppl. 1):1-49.
40. Makhani M, Yang J, Mirocha J, Low K, Pimentel M. Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome. J Clin Gastroenterol 2011;45:40-44.
41. Savarino E, Sconfienza L, Gemignani L, et al. Can we estimate orocecal transit time using MRI? A comparison with hydrogen breath test (hbt) in healthy volunteers. Preliminary results. Gut 2010;59(Suppl III):A360. [Abstract].
42. Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut 2011;60:334-340.
43. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958-963.
44. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566-1570.